The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation

McNamara, M; Sweeney, C; Antonarakis, ES; Armstrong, AJ

McNamara, M (reprint author), Duke Univ, Med Ctr, Durham, NC 27710 USA.; McNamara, M (reprint author), Duke Prostate & Urol Canc Ctr, Canc Inst, Durham, NC 27710 USA.

PROSTATE CANCER AND PROSTATIC DISEASES, 2018; 21 (3): 306

Abstract

Background Until 2015, androgen deprivation therapy (ADT) alone was the standard-of-care for metastatic hormone-sensitive prostate cancer (mHSPC). In ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索